Premium
NIDA asks information on optimal duration of medication for OUD
Author(s) -
Knopf Alison
Publication year - 2018
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32182
Subject(s) - buprenorphine , naltrexone , opioid use disorder , duration (music) , methadone , substance abuse , opioid abuse , psychology , opioid , medicine , psychiatry , art , receptor , literature
What is the optimal duration of treatment with methadone, buprenorphine or naltrexone for opioid use disorder (OUD)? The National Institute on Drug Abuse (NIDA) is asking stakeholders how to structure research to answer this question. Last month, NIDA issued a Request for Information (RFI) looking into this, with responses needed by Dec. 5.